Skip to main content
Neil Romberg, MD, Allergy & Immunology, Philadelphia, PA

NeilDavidRombergMD

Allergy & Immunology Philadelphia, PA

Associate Professor, University of Pennsylvania

Dr. Romberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Romberg's full profile

Already have an account?

  • Office

    3500 Civic Center Blvd
    Philadelphia, PA 19104
    Phone+1 215-590-1000
    Fax+1 267-425-9299

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Allergy and Immunology, 2008 - 2011
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Pediatrics, 2004 - 2008
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 2004

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2015 - 2024
  • CT State Medical License
    CT State Medical License 2008 - 2015
  • NY State Medical License
    NY State Medical License 2007 - 2009
  • American Board of Allergy and Immunology Allergy & Immunology

Publications & Presentations

PubMed

Journal Articles

  • BCL6 Inhibitor-Mediated Downregulation of pSAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation  
    Neil Romberg, MD, mBio
  • Reprogramming Human T Cell Function and Specificity with Non-Viral Genome Targeting  
    Neil Romberg, Antoni Ribas, Michael R Lee, Ruby Yu, Gary M Kupfer, Julia Carnevale, Jonathan H Esensten, P Jonathan Li, Han Li, Kevan C Herold, Alexander Marson, Nature

Press Mentions

  • Study Establishes Two Distinct Regulatory T Cell Populations
    Study Establishes Two Distinct Regulatory T Cell PopulationsApril 10th, 2023
  • CHOP-Led Study Identifies Two Different Regulatory T Cell Populations
    CHOP-Led Study Identifies Two Different Regulatory T Cell PopulationsApril 7th, 2023
  • Safest Treatment for Immune Disorder Not Cost-Effective, Study Finds
    Safest Treatment for Immune Disorder Not Cost-Effective, Study FindsNovember 18th, 2021
  • Join now to see all